Research Articles | Page 20 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation May 2023 Haematologica Aplastic Anemia
Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria Mar 2024 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia. Feb 2019 Haematologica Aplastic Anemia
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria Mar 2024 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Dec 2023 Haematologica Aplastic Anemia
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry Apr 2025 Haematologica Myelodysplastic Syndromes (MDS)
Granulocyte transfusions in severe aplastic anemia Dec 2023 Haematologica Aplastic Anemia
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial Apr 2025 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag Apr 2021 Haematologica Aplastic Anemia